课题基金 / 基金详情

Bioinspired Hybrid Scaffolds for Bone Tissue Engineering

Bioinspired Hybrid Scaffolds for Bone Tissue Engineering
用于骨组织工程的仿生混合支架
批准号:
519202302
负责人:
Professor Dr.-Ing. Chokri Cherif
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants (Transfer Project)
财政年份:
--
资助国家:
德国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Professor Dr.-Ing. Chokri Cherif的其他基金

相似基金

相关文献

中文摘要
翻译
骨组织由胶原纤维增强的羟基磷灰石(HAP)的分层结构组成,它由细胞(成骨细胞)产生,具有高强度和足够的延展性,以及再生能力。功能性骨替代材料必须反映这种性能特征,从而反映仿生孔径大小、机械性能和生物相容性。到目前为止,技术解决方案需要在生物和机械性能之间达成妥协,因为现有的方法和材料无法同时以满足要求的方式复制两者。细胞成分的高比例使得对骨结构的工程抽象和模拟非常具有挑战性,然而,这是理想的骨替代材料所必需的。这里提出的项目旨在通过探索一种模仿玻璃海绵Euectea aspergillum的仿生方法来填补这一空白。这种海绵还具有层次化结构,其构造原理可产生骨替代材料的积极性能,如高抗压强度、硬度和延展性。同时,所选择的材料方法旨在开发所需的生物特性。这需要基于模拟的纤维添加剂制造(FAM)技术,用于生产层次化结构、高度多孔和承重的骨替代支架,这种支架首次在材料和结构水平上结合了力学和促进再生的生物性能。这将特别克服骨缺损治疗中存在的挑战,并显著提高受影响患者的愈合成功率。开发的支架将进行广泛的机械和生物表征,以便为符合MDR(医疗器械法规)的风险评估奠定基础。目标值强烈依赖于随后的植入区域(例如,颌骨与股骨)。对于皮质骨的复制,需要达到100-200兆帕的压缩强度/弯曲硬度和5-20 GPA的弹性模数;对于松质骨,需要达到65-90%的孔隙率,由此开发的技术使在一个植入物中复制两者成为可能。最后,制造技术将在INNOTERE进行工业验证,从而将开发的技术从TRL4提高到TRL6。
英文摘要
Bone tissue consists of hierarchical structures of collagen fiber-reinforced hydroxyapatite (HAp), which are generated by cells (osteoblasts) and enable, among other things, high strengths with sufficient ductility, as well as regenerative capacity. Functional bone substitute materials must reflect this property profile and thus biomimetic pore sizes, mechanical properties and biocompatibility. Until now, technical solutions have required a compromise between biological and mechanical properties, since established methods and materials are not capable of reproducing both at the same time in a way that meets the requirements. The high proportion of cellular components makes an engineering abstraction and imitation of the bone structure very challenging, which is, however, necessary for an ideal bone substitute material. The project proposed here aims to fill this gap by exploring a biomimetic approach modeled on the glass sponge Euplectella aspergillum. This sponge is also hierarchically structured and exhibits construction principles that generate positive properties for bone substitution materials, such as high compressive strength, stiffness and ductility. At the same time, the chosen material approach is intended to develop the required biological properties. This requires the simulation-based development of Fiber Additive Manufacturing (FAM) for the production of hierarchically structured, highly porous and load-bearing scaffolds for bone replacement, which for the first time combine mechanical and regeneration-enhancing biological properties at the material and structural level. This should specifically overcome existing challenges in the therapy of bone defects and significantly increase the healing success of affected patients. The developed scaffolds will be extensively characterized mechanically and biologically in such a way that the basis for a MDR-compliant (medical device regulation) risk assessment will be laid. The target values are strongly dependent on the subsequent implantation region (e.g. jaw vs. femur). For the replication of the cortical bone, compressive strengths/bending stiffnesses of 100 - 200 MPa and elastic moduli of 5 - 20 GPa are to be achieved; for cancellous bone, porosities of 65 - 90 % are to be achieved, whereby the technology to be developed makes it possible to replicate both in one implant. Finally, the manufacturing technology will be industrially validated at INNOTERE, thus raising the developed technology from TRL4 to TRL6.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cellular, pressure actuated shape-flexible structures
Short-term dynamic stress-strain behavior of textile high-performance materials
Modelling and simulation of the hydrodynamic properties of protection and filter fabrics under consideration of service loads to predict their barrier and permeability properties
Developing of a repair method for carbon fibre reinforced plastics by using thermally activated oxide semiconductors
国内基金
海外基金
一种经心房覆膜血管支架植入 Hybrid Fontan 手术的 临床新技术研究
基于深度压缩技术的Hybrid像素探测器读出系统原型机研制
  • 批准号:
    11875146
  • 项目类别:
    面上项目
  • 资助金额:
    62.0万元
  • 批准年份:
    2018
  • 负责人:
    王东
  • 依托单位:
模拟胰岛“hybrid”修饰抗原诱导tolDC免疫保护1型糖尿病β细胞研究
  • 批准号:
    81770777
  • 项目类别:
    面上项目
  • 资助金额:
    56.0万元
  • 批准年份:
    2017
  • 负责人:
    顾愹
  • 依托单位:
PSMA靶向Hybrid-SiO2基纳米诊疗剂用于前列腺癌HIFU治疗及增效机制研究
  • 批准号:
    81601499
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    17.0万元
  • 批准年份:
    2016
  • 负责人:
    姚明华
  • 依托单位: